Selected research
Market Structure
Global HPV Vaccine for Men(Male HPV Vaccine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global HPV Vaccine for Men(Male HPV Vaccine) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for HPV Vaccine for Men(Male HPV Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for HPV Vaccine for Men(Male HPV Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for HPV Vaccine for Men(Male HPV Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for HPV Vaccine for Men(Male HPV Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of HPV Vaccine for Men(Male HPV Vaccine) include Bovaxbio, Kangle Guardian, Merck and Wantai Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global HPV Vaccine for Men(Male HPV Vaccine) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of HPV Vaccine for Men(Male HPV Vaccine) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents HPV Vaccine for Men(Male HPV Vaccine) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the HPV Vaccine for Men(Male HPV Vaccine) market size, projected growth trends, production technologies, key applications, and end-use industries.
HPV Vaccine for Men(Male HPV Vaccine) Segment by Company
Bovaxbio
Kangle Guardian
Merck
Wantai Biotech
HPV Vaccine for Men(Male HPV Vaccine) Segment by Type
Domestic
Imported
HPV Vaccine for Men(Male HPV Vaccine) Segment by Application
Penile Cancer and Precancerous Lesions
Genital Warts
Perineal Cancer and Precancerous Lesions
Perianal Cancer and Precancerous Lesions
Others
HPV Vaccine for Men(Male HPV Vaccine) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Vaccine for Men(Male HPV Vaccine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HPV Vaccine for Men(Male HPV Vaccine) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Vaccine for Men(Male HPV Vaccine).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the HPV Vaccine for Men(Male HPV Vaccine) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HPV Vaccine for Men(Male HPV Vaccine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HPV Vaccine for Men(Male HPV Vaccine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of HPV Vaccine for Men(Male HPV Vaccine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Domestic
- Imported
Applications
- Penile Cancer and Precancerous Lesions
- Genital Warts
- Perineal Cancer and Precancerous Lesions
- Perianal Cancer and Precancerous Lesions
- Others
Companies covered
- Bovaxbio
- Kangle Guardian
- Merck
- Wantai Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global HPV Vaccine for Men(Male HPV Vaccine) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global HPV Vaccine for Men(Male HPV Vaccine) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global HPV Vaccine for Men(Male HPV Vaccine) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global HPV Vaccine for Men(Male HPV Vaccine) Market Dynamics
- 2.1 HPV Vaccine for Men(Male HPV Vaccine) Industry Trends
- 2.2 HPV Vaccine for Men(Male HPV Vaccine) Industry Drivers
- 2.3 HPV Vaccine for Men(Male HPV Vaccine) Industry Opportunities and Challenges
- 2.4 HPV Vaccine for Men(Male HPV Vaccine) Industry Restraints
3 HPV Vaccine for Men(Male HPV Vaccine) Market by Manufacturers
- 3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Manufacturers (2021-2026)
- 3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Manufacturers (2021-2026)
- 3.3 Global HPV Vaccine for Men(Male HPV Vaccine) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global HPV Vaccine for Men(Male HPV Vaccine) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global HPV Vaccine for Men(Male HPV Vaccine) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global HPV Vaccine for Men(Male HPV Vaccine) Manufacturers, Product Type & Application
- 3.7 Global HPV Vaccine for Men(Male HPV Vaccine) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global HPV Vaccine for Men(Male HPV Vaccine) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 HPV Vaccine for Men(Male HPV Vaccine) Players Market Share by Revenue in 2025
- 3.8.3 2025 HPV Vaccine for Men(Male HPV Vaccine) Tier 1, Tier 2, and Tier 3
4 HPV Vaccine for Men(Male HPV Vaccine) Market by Type
- 4.1 HPV Vaccine for Men(Male HPV Vaccine) Type Introduction
- 4.1.1 Domestic
- 4.1.2 Imported
- 4.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type
- 4.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2021-2032)
- 4.2.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Type (2021-2032)
- 4.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type
- 4.3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type (2021-2032)
- 4.3.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Type (2021-2032)
5 HPV Vaccine for Men(Male HPV Vaccine) Market by Application
- 5.1 HPV Vaccine for Men(Male HPV Vaccine) Application Introduction
- 5.1.1 Penile Cancer and Precancerous Lesions
- 5.1.2 Genital Warts
- 5.1.3 Perineal Cancer and Precancerous Lesions
- 5.1.4 Perianal Cancer and Precancerous Lesions
- 5.1.5 Others
- 5.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application
- 5.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2021-2032)
- 5.2.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Application (2021-2032)
- 5.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application
- 5.3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application (2021-2032)
- 5.3.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Application (2021-2032)
6 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region
- 6.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (2021-2032)
- 6.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (2021-2026)
- 6.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America HPV Vaccine for Men(Male HPV Vaccine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe HPV Vaccine for Men(Male HPV Vaccine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region
- 7.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region
- 7.1.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region (2021-2026)
- 7.1.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region (2027-2032)
- 7.1.4 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America HPV Vaccine for Men(Male HPV Vaccine) Revenue (2021-2032)
- 7.2.2 North America HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe HPV Vaccine for Men(Male HPV Vaccine) Revenue (2021-2032)
- 7.3.2 Europe HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific HPV Vaccine for Men(Male HPV Vaccine) Revenue (2021-2032)
- 7.4.2 Asia-Pacific HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Bovaxbio
- 8.1.1 Bovaxbio Company Information
- 8.1.2 Bovaxbio Business Overview
- 8.1.3 Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
- 8.1.5 Bovaxbio Recent Developments
- 8.2 Kangle Guardian
- 8.2.1 Kangle Guardian Company Information
- 8.2.2 Kangle Guardian Business Overview
- 8.2.3 Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
- 8.2.5 Kangle Guardian Recent Developments
- 8.3 Merck
- 8.3.1 Merck Company Information
- 8.3.2 Merck Business Overview
- 8.3.3 Merck HPV Vaccine for Men(Male HPV Vaccine) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
- 8.3.5 Merck Recent Developments
- 8.4 Wantai Biotech
- 8.4.1 Wantai Biotech Company Information
- 8.4.2 Wantai Biotech Business Overview
- 8.4.3 Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
- 8.4.5 Wantai Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 HPV Vaccine for Men(Male HPV Vaccine) Value Chain Analysis
- 9.1.1 HPV Vaccine for Men(Male HPV Vaccine) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 HPV Vaccine for Men(Male HPV Vaccine) Production Mode & Process
- 9.2 HPV Vaccine for Men(Male HPV Vaccine) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 HPV Vaccine for Men(Male HPV Vaccine) Distributors
- 9.2.3 HPV Vaccine for Men(Male HPV Vaccine) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst